These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 94352)

  • 1. Comparison of the antibodies elicited by the individual structural polypeptides of foot-and mouth disease and polio viruses.
    Meloen RH; Rowlands DJ; Brown F
    J Gen Virol; 1979 Dec; 45(3):761-3. PubMed ID: 94352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of neutralizing antibodies and immunity in vaccinated guinea pigs by cyanogen bromide-peptides of VP3 of foot-and-mouth disease virus.
    Kaaden OR; Adam KH; Strohmeier K
    J Gen Virol; 1977 Feb; 34(2):397-400. PubMed ID: 65445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monospecific antisera against capsid polypeptides of poliovirus type 1 distinguish antigenic structures of poliovirus proteins.
    Wiegers KJ; Dernick R
    J Gen Virol; 1983 Apr; 64 (Pt 4)():777-85. PubMed ID: 6300300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemical studies of polioviruses: identification of immunoreactive virus capsid polypeptides.
    Thorpe R; Minor PD; Mackay A; Schild GC; Spitz M
    J Gen Virol; 1982 Dec; 63(2):487-92. PubMed ID: 6185628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of foot-and-mouth disease virus type O1 Brugge neutralization epitopes using monoclonal antibodies.
    Stave JW; Card JL; Morgan DO
    J Gen Virol; 1986 Oct; 67 ( Pt 10)():2083-92. PubMed ID: 2428926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four independent antigenic determinants on the capsid polypeptides of aphthovirus.
    Haresnape JM; McCahon D
    J Gen Virol; 1983 Nov; 64 (Pt 11)():2345-55. PubMed ID: 6196438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of neutralizing antibodies by type 1 poliovirus VP1 capsid polypeptide.
    Crainic R; Blondel B; Horaud F
    Dev Biol Stand; 1983; 55():185-9. PubMed ID: 6329856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nature of the antibody response to the foot-and-mouth disease virus particle, its 12S protein subunit and the isolated immunizing polypeptide VP1.
    Cartwright B; Morrell DJ; Brown F
    J Gen Virol; 1982 Dec; 63(2):375-81. PubMed ID: 6296284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenic and cell attachment sites of FMDV: further evidence for their location in a single capsid polypeptide.
    Cavanagh D; Sangar DV; Rowlands DJ; Brown F
    J Gen Virol; 1977 Apr; 35(1):149-58. PubMed ID: 192841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of neutralizing monoclonal antibodies to empty capsids of poliovirus can be blocked by monospecific antisera to structural polypeptides VP1 and VP2.
    Uhlig H; Haardt F; Dernick R
    Arch Virol; 1985; 83(3-4):295-303. PubMed ID: 2578787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif.
    Brown F; Benkirane N; Limal D; Halimi H; Newman JF; Van Regenmortel MH; Briand JP; Muller S
    Vaccine; 1999 Aug; 18(1-2):50-6. PubMed ID: 10501234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody response to 146S particle, 12S protein subunit and isolated VP1 polypeptide of foot-and-mouth disease virus type Asia-1.
    Rao MG; Butchaiah G; Sen AK
    Vet Microbiol; 1994 Mar; 39(1-2):135-43. PubMed ID: 8203119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies elicited by a biosynthetic peptide related to a major immunogenic area of FMDV A12.
    Borca MV; Moore DM; Srikumaran S; Morgan DO
    Viral Immunol; 1990; 3(2):147-60. PubMed ID: 1694429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The main antigenic determinant detected by neutralizing monoclonal antibodies on the intact foot-and-mouth disease virus particle is absent from isolated VPI.
    Meloen RH; Briaire J; Woortmeyer RJ; van Zaane D
    J Gen Virol; 1983 May; 64(Pt 5):1193-8. PubMed ID: 6188800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the cross-reacting antigens on the intact foot-and-mouth disease virus and its 12S Subunits with antisera against the structural proteins.
    Meloen RH; Briaire J
    J Gen Virol; 1980 Nov; 51(Pt 1):107-16. PubMed ID: 6257830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic and structural relatedness among non-capsid and capsid polypeptides of polioviruses belonging to different serotypes.
    Romanova LI; Tolskaya EA; Agol VI
    J Gen Virol; 1981 Feb; 52(Pt 2):279-89. PubMed ID: 6169783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus.
    Bachrach HL; Moore DM; McKercher PD; Polatnick J
    J Immunol; 1975 Dec; 115(6):1636-41. PubMed ID: 171309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization epitopes on poliovirus type 3 particles: an analysis using monoclonal antibodies.
    Ferguson M; Minor PD; Magrath DI; Qui YH; Spitz M; Schild GC
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():197-201. PubMed ID: 6198447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and immune response of a protein produced by a cDNA clone of foot and mouth disease virus, type Asia 1 63/72.
    Suryanarayana VV; Venkataramanan R; Rao BU; Padayatty JD
    Biochem Int; 1992 May; 26(6):1003-16. PubMed ID: 1378734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of neutralizing antibodies by poliovirus capsid polypeptides VP1, VP2 and VP3.
    van der Marel P; Hazendonk TG; Henneke MA; van Wezel AL
    Vaccine; 1983 Dec; 1(1):17-22. PubMed ID: 6099638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.